Skip to main content
Clinical Trials/JPRN-UMIN000050925
JPRN-UMIN000050925
Recruiting
未知

An observational study of the safety and efficacy of nivolumab as adjuvant treatment for esophageal cancer using the Comprehensive Registry of Esophageal Cancer in the National Clinical Database. - An observational study of the safety and efficacy of adjuvant nivolumab therapy for esophageal cancer.

Japanese Foundation For Cancer Research0 sites1,750 target enrollmentApril 25, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Esophageal cancer or esophagogastric cancer
Sponsor
Japanese Foundation For Cancer Research
Enrollment
1750
Status
Recruiting
Last Updated
2 years ago